WallStreetZenWallStreetZen

NYSE: ANVS
Annovis Bio Inc Stock Forecast, Predictions & Price Target

Analyst price target for ANVS

Based on 4 analysts offering 12 month price targets for Annovis Bio Inc.
Min Forecast
$21.00+164.82%
Avg Forecast
$36.00+353.97%
Max Forecast
$67.00+744.89%

Should I buy or sell ANVS stock?

Based on 4 analysts offering ratings for Annovis Bio Inc.
Strong Buy
Strong Buy
3 analysts 75%
Buy
1 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ANVS stock forecasts and price targets.

ANVS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-10-01
lockedlocked$00.00+00.00%2024-08-15
lockedlocked$00.00+00.00%2024-07-02
lockedlocked$00.00+00.00%2024-06-04
lockedlocked$00.00+00.00%2024-04-30

1 of 1

Forecast return on equity

Is ANVS forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is ANVS forecast to generate an efficient return on assets?
Company
-475.97%
Industry
7.63%
ANVS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ANVS earnings per share forecast

What is ANVS's earnings per share in the next 2 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$2.53
Avg 2 year Forecast
-$1.84

ANVS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ANVS$7.93$36.00+353.97%Strong Buy
IMAB$1.27$8.00+529.92%Buy
INMB$5.14$22.00+328.02%Buy
GNTA$5.80$25.00+331.03%Buy
ELDN$2.68$16.00+497.01%Buy

Annovis Bio Stock Forecast FAQ

Is Annovis Bio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSE: ANVS) stock is to Strong Buy ANVS stock.

Out of 4 analysts, 3 (75%) are recommending ANVS as a Strong Buy, 1 (25%) are recommending ANVS as a Buy, 0 (0%) are recommending ANVS as a Hold, 0 (0%) are recommending ANVS as a Sell, and 0 (0%) are recommending ANVS as a Strong Sell.

If you're new to stock investing, here's how to buy Annovis Bio stock.

What is ANVS's earnings growth forecast for 2024-2025?

(NYSE: ANVS) Annovis Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.57%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.05%.

Annovis Bio's earnings in 2024 is -$43,017,369.On average, 3 Wall Street analysts forecast ANVS's earnings for 2024 to be -$32,983,587, with the lowest ANVS earnings forecast at -$47,125,005, and the highest ANVS earnings forecast at -$25,585,875.

In 2025, ANVS is forecast to generate -$24,019,393 in earnings, with the lowest earnings forecast at -$28,457,759 and the highest earnings forecast at -$19,581,027.

What is ANVS's forecast return on equity (ROE) for 2024-2025?

(NYSE: ANVS) forecast ROE is N/A, which is considered weak.

What is ANVS's Price Target?

According to 4 Wall Street analysts that have issued a 1 year ANVS price target, the average ANVS price target is $36.00, with the highest ANVS stock price forecast at $67.00 and the lowest ANVS stock price forecast at $21.00.

On average, Wall Street analysts predict that Annovis Bio's share price could reach $36.00 by Oct 1, 2025. The average Annovis Bio stock price prediction forecasts a potential upside of 353.97% from the current ANVS share price of $7.93.

What is ANVS's Earnings Per Share (EPS) forecast for 2024-2025?

(NYSE: ANVS) Annovis Bio's current Earnings Per Share (EPS) is -$4.50. On average, analysts forecast that ANVS's EPS will be -$2.53 for 2024, with the lowest EPS forecast at -$3.61, and the highest EPS forecast at -$1.96. In 2025, ANVS's EPS is forecast to hit -$1.84 (min: -$2.18, max: -$1.50).

What is ANVS's forecast return on assets (ROA) for 2024-2025?

(NYSE: ANVS) forecast ROA is -475.97%, which is lower than the forecast US Biotechnology industry average of 7.63%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.